KR102070893B1 - 고프로락틴혈증의 진단용 조성물 및 약물 치료의 반응성을 예측하기 위한 정보를 제공하는 방법 - Google Patents

고프로락틴혈증의 진단용 조성물 및 약물 치료의 반응성을 예측하기 위한 정보를 제공하는 방법 Download PDF

Info

Publication number
KR102070893B1
KR102070893B1 KR1020180125094A KR20180125094A KR102070893B1 KR 102070893 B1 KR102070893 B1 KR 102070893B1 KR 1020180125094 A KR1020180125094 A KR 1020180125094A KR 20180125094 A KR20180125094 A KR 20180125094A KR 102070893 B1 KR102070893 B1 KR 102070893B1
Authority
KR
South Korea
Prior art keywords
hyperprolactinemia
mir
hsa
mirna
present
Prior art date
Application number
KR1020180125094A
Other languages
English (en)
Korean (ko)
Inventor
구철룡
이은직
이양종
Original Assignee
연세대학교 산학협력단
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 연세대학교 산학협력단 filed Critical 연세대학교 산학협력단
Priority to KR1020180125094A priority Critical patent/KR102070893B1/ko
Priority to PCT/KR2019/013295 priority patent/WO2020080739A1/fr
Application granted granted Critical
Publication of KR102070893B1 publication Critical patent/KR102070893B1/ko

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
KR1020180125094A 2018-10-19 2018-10-19 고프로락틴혈증의 진단용 조성물 및 약물 치료의 반응성을 예측하기 위한 정보를 제공하는 방법 KR102070893B1 (ko)

Priority Applications (2)

Application Number Priority Date Filing Date Title
KR1020180125094A KR102070893B1 (ko) 2018-10-19 2018-10-19 고프로락틴혈증의 진단용 조성물 및 약물 치료의 반응성을 예측하기 위한 정보를 제공하는 방법
PCT/KR2019/013295 WO2020080739A1 (fr) 2018-10-19 2019-10-10 Composition pour le diagnostic de l'hyperprolactinémie, et procédé pour fournir des informations permettant de prédire une réponse à un traitement médicamenteux

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020180125094A KR102070893B1 (ko) 2018-10-19 2018-10-19 고프로락틴혈증의 진단용 조성물 및 약물 치료의 반응성을 예측하기 위한 정보를 제공하는 방법

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020200007892A Division KR102162110B1 (ko) 2020-01-21 2020-01-21 고프로락틴혈증의 진단용 조성물 및 약물 치료의 반응성을 예측하기 위한 정보를 제공하는 방법

Publications (1)

Publication Number Publication Date
KR102070893B1 true KR102070893B1 (ko) 2020-01-29

Family

ID=69322180

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020180125094A KR102070893B1 (ko) 2018-10-19 2018-10-19 고프로락틴혈증의 진단용 조성물 및 약물 치료의 반응성을 예측하기 위한 정보를 제공하는 방법

Country Status (2)

Country Link
KR (1) KR102070893B1 (fr)
WO (1) WO2020080739A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112501304A (zh) * 2020-12-17 2021-03-16 浙江清华长三角研究院 miRNA-424作为脑垂体瘤诊断标志物的应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140141986A1 (en) * 2011-02-22 2014-05-22 David Spetzler Circulating biomarkers

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DeVore SB et al., Mol Cell Biol. Vol.38(19): e00084-18. (온라인공개 2018.07.09.) *
Feng Y et al., Horm Metab Res Vol.50: 179-192. (온라인공개 2018.01.19.) *
Triebel J et al., Front Endocrinol (Lausanne). Vol.8: 342. (온라인공개 2017.12.11.) *

Also Published As

Publication number Publication date
WO2020080739A1 (fr) 2020-04-23

Similar Documents

Publication Publication Date Title
KR102622309B1 (ko) 염색체 상호작용의 검출
JP2019059733A (ja) 前立腺癌マーカーとしてのホスホジエステラーゼ４ｄ７
CA2900022A1 (fr) Procede de diagnostic non invasif pour diagnostiquer le cancer de la vessie
WO2007128884A1 (fr) Gènes et marqueurs atypiques dans le diabète de type 2 et l'obésité
EP3294903B1 (fr) Procédé de diagnostic in vitro de synucléinopathies utilisant des transcriptions du gène de l'alpha-synucléine
CN106662543B (zh) 肺癌患者中的非侵入性基因突变检测
MXPA03004928A (es) Metodo para determinar un regimen quimioterapeutico sobre la base de la expresion ts y ercci.
KR20190024923A (ko) 진행성 위암 환자의 수술 후 예후 또는 항암제 적합성 예측 시스템
JP2008532495A (ja) 神経精神障害に関するバイオマーカーの検出
CN106967719B (zh) 一种长链非编码rna作为前列腺癌分子标志物的应用
WO2018220185A1 (fr) Nouveaux biomarqueurs d'arn circulaire pour l'insuffisance cardiaque
KR102070893B1 (ko) 고프로락틴혈증의 진단용 조성물 및 약물 치료의 반응성을 예측하기 위한 정보를 제공하는 방법
CN108715893B (zh) 一组与放疗引起的放射性脑损伤相关的snp标志物及其应用
US11047012B2 (en) Method for detecting the risk and prognosis of adult-onset Still's disease
CN108753980A (zh) 一种甲状腺微小乳头状癌的转移性筛查的筛查试剂盒
KR102162110B1 (ko) 고프로락틴혈증의 진단용 조성물 및 약물 치료의 반응성을 예측하기 위한 정보를 제공하는 방법
WO2015061534A1 (fr) Méthodes de diagnostic, de dépistage, d'identification, de suivi et de traitement de réactions tissulaires locales indésirables provoquées par des implants orthopédiques
KR20220023319A (ko) 연령 관련 황반변성 진단용 바이오마커 및 이의 용도
CN110577994B (zh) 无创诊断男性骨质疏松症的产品
CN108753959B (zh) 一种位于disc1fp1基因的与放疗引起的放射性脑损伤相关的snp标志物及其应用
KR20100037639A (ko) Ｅｇｆｒ 억제제를 이용한 치료에 대한 예측 마커
JP2014506117A (ja) 軽度の炎症を検出するための方法
CN108715895B (zh) 一种位于kctd1基因的与放疗引起的放射性脑损伤相关的snp标志物及其应用
CN107365859A (zh) LncRNA作为诊治骨肉瘤的分子标志物
Bujko et al. Microsatellite instability analysis in pituitary adenomas

Legal Events

Date Code Title Description
A107 Divisional application of patent
GRNT Written decision to grant